These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12831059)
1. Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis. Schuch G; Kisker O; Atala A; Soker S Angiogenesis; 2002; 5(3):181-90. PubMed ID: 12831059 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189 [TBL] [Abstract][Full Text] [Related]
4. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248 [TBL] [Abstract][Full Text] [Related]
5. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [TBL] [Abstract][Full Text] [Related]
8. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts. Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Joseph IB; Isaacs JT Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270 [TBL] [Abstract][Full Text] [Related]
10. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444 [TBL] [Abstract][Full Text] [Related]
11. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Schwarte-Waldhoff I; Volpert OV; Bouck NP; Sipos B; Hahn SA; Klein-Scory S; Lüttges J; Klöppel G; Graeven U; Eilert-Micus C; Hintelmann A; Schmiegel W Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9624-9. PubMed ID: 10944227 [TBL] [Abstract][Full Text] [Related]
13. 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer. Bianco C; Tortora G; Baldassarre G; Caputo R; Fontanini G; Chinè S; Bianco AR; Ciardiello F Clin Cancer Res; 1997 Mar; 3(3):439-48. PubMed ID: 9815703 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway]. Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Hoshida T; Sunamura M; Duda DG; Egawa S; Miyazaki S; Shineha R; Hamada H; Ohtani H; Satomi S; Matsuno S Pancreas; 2002 Aug; 25(2):111-21. PubMed ID: 12142732 [TBL] [Abstract][Full Text] [Related]
16. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR. Egawa S; Tsutsumi M; Konishi Y; Kobari M; Matsuno S; Nagasaki K; Futami H; Yamaguchi K Gastroenterology; 1995 May; 108(5):1526-33. PubMed ID: 7537236 [TBL] [Abstract][Full Text] [Related]
17. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694 [TBL] [Abstract][Full Text] [Related]
18. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537 [TBL] [Abstract][Full Text] [Related]
19. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor. Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression. Aonuma M; Saeki Y; Akimoto T; Nakayama Y; Hattori C; Yoshitake Y; Nishikawa K; Shibuya M; Tanaka NG Int J Exp Pathol; 1999 Oct; 80(5):271-81. PubMed ID: 10607018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]